Pharmacy benefits manager CVS Caremark (CVS) is being probed by the U.S. Department of Health on suspicions of Medicare fraud, according to the L.A. Times. Shares slipped 1.1%.
Your one-stop shop for 2012 stock recommendations and market predictions.
>To contact the writer of this article, click here: Andrea Tse. Follow @Commodity_Bull